FIGS Gets a Fresh Boost: Oppenheimer Upgrades to Outperform, Sees a Sustained Recovery Ahead

Oppenheimer upgrades FIGS stock to Outperform from Perform with $22 target, citing sustained recovery, improved ops, and undervalued long-term growth in healthcare apparel.